[ad_1]
On September 6, the third round of trials in Great Britain was abruptly halted due to the illness of a volunteer. Trials in the United States, Brazil and South Africa were also hastily closed. But even on Wednesday, the Serum Institute did not close the trial.
Own report: This time, the Oxford vaccine trial also stopped in India. Britain’s fire is also in India this time. Same formula. But several companies are developing vaccines. AstraZeneca is testing Oxford medicine in Great Britain. And in India, the vaccine is manufactured by the Pune Serum Institute.
On September 6, the third round of trials in Great Britain was abruptly halted due to the illness of a volunteer. Trials in the United States, Brazil and South Africa were also hastily closed. But even on Wednesday, the Serum Institute did not close the trial.
Why was the trial not closed after the incident in Britain? The Comptroller General of Drugs of India (DGCI) sent a notice of show of cause to the Serum Institute on this matter. Why was the DGCI not informed of the decision to close the AstraZeneca lawsuit? The question is why the trial will not be closed until the safety of the volunteers is guaranteed in this notice. DGCI question.
After receiving the notice, the Serum Institute announced the decision to close the trial in a short statement. The trial is set to continue until a full review of the UK case is completed. Although sources said a volunteer who fell ill in Britain had a spinal cord problem, another volunteer was diagnosed with a nerve problem in July and the trial was temporarily suspended.
People are faced with uncertainty again as the test of the formula that the corona antidote was expected to yield early next year is closed. Although Astrageneca says that this pitfall is not likely to cause significant harm. The vaccine will be released within the proposed time ensuring complete protection.
